State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Tianjin Hospital, Tianjin, 300211, China.
J Ethnopharmacol. 2023 Nov 15;316:116727. doi: 10.1016/j.jep.2023.116727. Epub 2023 Jun 3.
Angelicae pubescentis radix (APR) has a long history in the treatment of rheumatoid arthritis (RA) in China. It has the effects of dispelling wind to eliminate dampness, removing arthralgia and stopping pain in the Chinese Pharmacopeia, but its mechanisms was remained unclear. Columbianadin (CBN), one of the main bioactive compounds of APR, has many pharmacological effects including anti-inflammatory and immunosuppression. However, there are few reports on therapeutic effect of CBN on RA.
A comprehensive strategy via incorporating pharmacodynamics, microbiomics, metabolomics, and multiple molecular biological methods was adopted to evaluate the therapeutic effects of CBN on collagen-induced arthritis (CIA) mice and explore the potential mechanisms.
A variety of pharmacodynamic methods were used to evaluate the therapeutic effect of CBN on CIA mice. The microbial and metabolic characteristics of CBN anti-RA were obtained by metabolomics and 16S rRNA sequencing technology. The potential mechanism of CBN anti-RA was predicted through bioinformatics network analysis, and verified by a variety of molecular biology methods.
CBN can effectively improved symptoms of rheumatoid arthritis in CIA mice, including paw swelling and arthritic scores. The inflammatory and oxidative stress were effectively regulated by the treatment of CBN. The fecal microbial communities and serum and urine metabolic compositions were significantly altered in CIA mice, CBN can ameliorate the CIA-associated gut microbiota dysbiosis, and regulate the disturbance of serum and urine metabolome. The acute toxicity test showed that the LD50 of CBN was greater than 2000 mg kg.
CBN exert anti-RA effects from four perspectives: inhibiting inflammatory response, regulating oxidative stress, and improving changes in gut microbiota and metabolites. The JAK1/STAT3, NF-κB and Keap1/Nrf2 pathway may be important mechanism for CBN's inflammatory response and oxidative stress activity. CBN could be considered as a potential anti-RA drug for further study.
在中国,当归(APR)已有很长的历史用于治疗类风湿关节炎(RA)。《中国药典》记载其具有祛风除湿、通络止痛的功效,但作用机制尚不清楚。当归中的主要生物活性化合物之一,藁本内酯(CBN)具有抗炎和免疫抑制等多种药理作用。然而,关于 CBN 治疗 RA 的报道很少。
本研究采用综合策略,结合药效学、微生物组学、代谢组学和多种分子生物学方法,评价 CBN 对胶原诱导性关节炎(CIA)小鼠的治疗作用,并探讨其潜在机制。
采用多种药效学方法评价 CBN 对 CIA 小鼠的治疗作用。通过代谢组学和 16S rRNA 测序技术获得 CBN 抗 RA 的微生物和代谢特征。通过生物信息学网络分析预测 CBN 抗 RA 的潜在机制,并通过多种分子生物学方法进行验证。
CBN 能有效改善 CIA 小鼠的类风湿关节炎症状,包括爪肿胀和关节炎评分。CBN 治疗可有效调节炎症和氧化应激。CIA 小鼠的粪便微生物群和血清及尿液代谢物组成发生显著改变,CBN 可改善 CIA 相关的肠道微生物失调,并调节血清和尿液代谢组的紊乱。急性毒性试验表明,CBN 的 LD50 大于 2000mg/kg。
CBN 从四个方面发挥抗 RA 作用:抑制炎症反应、调节氧化应激、改善肠道微生物群和代谢物的变化。JAK1/STAT3、NF-κB 和 Keap1/Nrf2 通路可能是 CBN 抗炎反应和氧化应激活性的重要机制。CBN 可作为一种有潜力的抗 RA 药物进一步研究。